Bayer

Bayer AG is a German multinational pharmaceutical and life sciences company founded in 1863. It operates globally in over 90 countries with approximately 100,000 employees as of 2024. Bayer is structured into three main business segments: Pharmaceuticals, Consumer Health, and Crop Science, with significant global operations and an extensive patent portfolio. The company is a leader in agricultural products, prescription medicines, and over-the-counter health products. It also focuses on innovative solutions for healthcare and agricultural challenges.

The current dilemma for students to address are issues related to Bayer’s transition to a new operating model called Dynamic Shared Ownership (DSO). This model, introduced under the leadership of CEO Bill Anderson, aims to flatten the corporate hierarchy and create a nimbler, customer-centric organization. The transition involves removing the existing hierarchical structure, which previously consisted of 12 management layers, and replacing it with self-managed teams. This structural change was referred to internally as the "hardware."

The initial steps under DSO included substantial organizational redesign, involving layoffs and the establishment of self-managed teams. The Board of Management successfully halved the number of management layers to five or six and replaced thousands of middle managers with self-managed teams. A complementary aspect of DSO, labeled the "software," focused on fostering cultural changes to promote new mindsets, norms, and behaviors among Bayer’s nearly 100,000 employees.

Notwithstanding several early wins, the Board of Management is now grappling with implementing new talent management and personnel policies that align with the DSO model. Existing HR processes and systems, which are designed for a hierarchical organization, need to be reinvented. Questions about compensation, career pathing, and performance metrics must be addressed to ensure these new systems support the DSO framework effectively.